Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer. The Company is advancing [225Ac]-FPI-1434, its lead product candidate that combines the precision targeting of an antibody with the potency of alpha-particle emitting medical isotopes to specifically attack and eradicate cancer cells across multiple tumor types. It also operates Fast-Clear™, a linker technology platform that promotes the rapid excretion of medical isotopes that are not specifically bound to cancer cells.
|Employees (est.) (Mar 2020)||42|
Fusion Pharmaceuticals total Funding
Fusion Pharmaceuticals latest funding size
Time since last funding
|3 months ago|
Fusion Pharmaceuticals investors
|Adams Street Partners, Johnson & Johnson Development Corporation, TPG Biotech, HealthCap, Genesys Capital, Perceptive Advisors, Rock Springs Capital, Johnson & Johnson Innovation, OrbiMed, Seroba Life Sciences, Pivotal bioVenture Partners, Varian Medical Systems, FACIT.com, FACIT, CPPIB|
Fusion Pharmaceuticals has 77 Twitter Followers. The number of followers has increased 0.3% month over month and increased 22.8% quarter over quarter
When was Fusion Pharmaceuticals founded?
Fusion Pharmaceuticals was founded in 2014.
Who are Fusion Pharmaceuticals key executives?
Fusion Pharmaceuticals's key executives are John Valliant, Eric Burak and Marc Schwabish.
How many employees does Fusion Pharmaceuticals have?
Fusion Pharmaceuticals has 42 employees.
Who are Fusion Pharmaceuticals competitors?
Competitors of Fusion Pharmaceuticals include Century Therapeutics, Prelude Therapeutics and Actuate Therapeutics.
Where is Fusion Pharmaceuticals headquarters?
Fusion Pharmaceuticals headquarters is located at 270 Longwood Rd S, Hamilton.
Where are Fusion Pharmaceuticals offices?
Fusion Pharmaceuticals has offices in Hamilton and Boston.
How many offices does Fusion Pharmaceuticals have?
Fusion Pharmaceuticals has 2 offices.
Receive alerts for 300+ data fields across thousands of companies